Onxeo S.A.: Combined General Meeting of August 17, 2022: Onx

Company to submit delisting request to Nasdaq Regulatory News: Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North: ONXEO), a clinical-stage biotechnology company specializing in the development

Related Keywords

Denmark , Copenhagen , Køavn , Danish , Arthur Rouill , Onxeo Sa Euronext , Emmanuel Huynh , Company Group , Nasdaq , Euronext Growth , Nasdaq First North , Combined General Meeting , Nasdaq First , General Meetings , Euronext Paris , Onxeo , Combined , Eneral , Meeting , August , 022 , Shareholders , Pprove , Withdrawal , Rom , First , North , Market ,